Postdoc - Cancer genomics and bioinformatics

Novartis Institutes for Biomedical Research
Job Location
Cambridge, MA 02139
Job Description

The Next Generation Diagnostics Group in Oncology in Novartis Institutes for BioMedical Research (NIBR) in Cambridge, MA currently has an opportunity for a postdoctoral scholar interested in the areas of cancer genomic biomarker discovery and integrative genomics. We are interested in developing integrative approaches to germline genetic data and tumor genomic data to identify biomarkers for tumor progression and response to therapy. The postdoc will work in a highly multidisciplinary environment and will have the opportunity to blend rigorous statistical approaches and bioinformatics with detailed biological understanding. Please see for more details about our research interests.



We are seeking applications from candidates with a background in cancer biology, genomics, genetics, computational biology, or a related field. Experience with large genomic datasets and expertise in bioinformatics tools including proficiency in programming (e.g. R, python) is preferred. 

How to Apply

The NIBR postdoc website has further details about our postdoctoral program, mentor profiles, and information on how to apply ( 

About Our Organization

The NIBR Postdoctoral Program provides postdoctoral scholars a unique opportunity to perform innovative, fundamental research in a drug discovery setting. Postdocs design and conduct their research with guidance from a principal investigator at NIBR, and an academic advisor where appropriate. Our postdocs present their work at major research conferences and aim to publish their results in leading peer-reviewed journals. We encourage applications from candidates who wish to pursue a career in academia or industry. 

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.

Social scientists report that the image of the 'lone scientist' might be deterring US students from STEM careers.